0001654954-22-005334.txt : 20220425 0001654954-22-005334.hdr.sgml : 20220425 20220425092642 ACCESSION NUMBER: 0001654954-22-005334 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20220425 DATE AS OF CHANGE: 20220425 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Novusterra Inc CENTRAL INDEX KEY: 0001831114 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS METAL ORES [1090] IRS NUMBER: 853129871 STATE OF INCORPORATION: FL FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-259924 FILM NUMBER: 22847561 BUSINESS ADDRESS: STREET 1: 7135 COLLINS AVE STREET 2: NO.624 CITY: MIAMI BEACH STATE: FL ZIP: 33141 BUSINESS PHONE: 305-865-8193 MAIL ADDRESS: STREET 1: 7135 COLLINS AVE STREET 2: NO.624 CITY: MIAMI BEACH STATE: FL ZIP: 33141 S-1/A 1 nvstrr_s1a.htm FORM S-1/A nvstrr_s1a.htm

As filed with the Securities and Exchange Commission on April 25, 2022

 

Registration No. 333- 259924 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

AMENDMENT NO. 15

to

Form S-1

 

REGISTRATION STATEMENT

Under

The Securities Act of 1933

 

Novusterra Inc.

(Exact name of registrant as specified in its charter)

 

Florida

 

3990

 

85-3129871

(State or other jurisdiction of

 

(Primary Standard Industrial

 

(IRS Employer

incorporation or organization)

 

Classification Code Number)

 

Identification No.)

 

561 NE 79th Street, Suite 325

Miami, FL 33138

(786) 473-6233

(Address, including zip code, and telephone number,

including area code, of registrant’s principal executive offices)

 

I. Andrew Weeraratne

Chief Executive Officer

561 NE 79th Street, Suite 325

Miami, FL 33138

(786) 473-6233

(Name, address, including zip code, and telephone number,

including area code, of agent for service)

 

Please send copies of all communications to:

 

Clifford J. Hunt Esq.

Law Office of Clifford J. Hunt, P.A.

8200 Seminole Boulevard

Seminole, Florida 33772

(727) 471-0444

 

M. Ali Panjwani, Esq.

Pryor Cashman LLP

7 Times Square

New York, New York 10036

(212) 421-4100

 

As soon as practicable after this registration statement becomes effective

(Approximate date of commencement of proposed sale to the public)

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box: ☒

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Securities Exchange Act of 1934.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging Growth Company

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

 

 

   

THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF THE SECURITIES ACT OF 1933, AS AMENDED, OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(A), MAY DETERMINE.

 

 

i

 

   

THE INFORMATION IN THIS PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED. WE MAY NOT SELL THESE SECURITIES UNTIL THE REGISTRATION STATEMENT FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN OFFER TO SELL THESE SECURITIES AND WE ARE NOT SOLICITING OFFERS TO BUY THESE SECURITIES IN ANY STATE WHERE THE OFFER OR SALE IS NOT PERMITTED.

 

SUBJECT TO COMPLETION, DATED __________, 2022

 

PROSPECTUS

  

Units Consisting of 3,750,000 Shares of Common Stock and Warrants to purchase up to 7,500,000 Shares of Common Stock

 

Novusterra Inc. 

 

 

 

ii

 

 

This amendment number 15 to Novusterra Inc., Form S-1 is filed solely for the purpose of filing a revised legal opinion as of the filing date and update the attached exhibit.

 

EXHIBITS

 

Exhibit No.

 

Description

 

Filed with

1.1

 

Form of Underwriting Agreement

 

Previously filed

 

 

 

 

 

3.1

 

Articles of Incorporation Novusterra Inc.

 

Previously filed

 

 

 

 

 

3.2

 

Amended Articles of Incorporation Novusterra Inc.

 

Previously filed

 

 

 

 

 

3.3

 

Bylaws of Novusterra Inc.

 

Previously filed

 

 

 

 

 

4.1

 

Form of Warrant Agency Agreement, including Form of Warrant Certificate

 

Previously filed

 

 

 

 

 

4.2

 

Common Stock Purchase Warrant

 

Previously filed

 

 

 

 

 

4.3

 

Form of Underwriters’ Warrant

 

Previously filed

 

 

 

 

 

5.1

 

Opinion of Counsel

 

Filed herewith

 

 

 

 

 

10.1

 

Agreement dated March 31, 2021 by and between Novusterra Inc., and American Resources Corp.

 

Previously filed

 

 

 

 

 

10.2

 

Graphene Development Agreement dated as of March 31, 2021 by and between Novusterra Inc. and American Resources Corporation

 

Previously filed

 

 

 

 

 

10.3

 

First Amendment to Graphene Development Agreement dated as of May 14, 2021 by and between Novusterra Inc. and American Resources Corporation

 

Previously filed

 

 

 

 

 

10.4

 

Loan payable Agreement dated as of September 24, 2020 by and between Novusterra Inc., and I Andrew Weeraratne

 

Previously filed

 

 

 

 

 

10.5

 

Carbon Purchase Agreement dated as of April 24, 2021 by and between Novusterra Inc., and American Resources Corporation

 

Previously filed

 

 

 

 

 

10.6

 

The Exclusive License Agreement signed on February 10, 2021 by and between American Resources Corporation and Ohio University

 

Previously filed

 

 

 

 

 

14.1

 

Code of Conduct

 

Previously filed

 

 

 

 

 

14.2

 

Financial Code of Ethics

 

Previously filed

 

 

 

 

 

23.1

 

Consent of Auditor- Paris, Kreit & Chiu CPA LLP (formerly Benjamin and Ko)

 

Previously filed

 

 

 

 

 

23.2

 

Consent of Counsel (included in Exhibit 5.1)

 

Filed herewith

 

 

 

 

 

24.1

 

Power of Attorney

 

Previously filed

 

 

 

 

 

99.1

 

Audit Committee Charter

 

Previously filed

 

 

 

 

 

99.2

 

Compensation Committee Charter

 

Previously filed

 

 

 

 

 

99.3

 

Nominating Committee Charter

 

Previously filed

 

 

 

 

 

107

 

Filing Fee Table

 

Previously filed

 

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Amendment No. 15 to the registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the, State of Florida on April 25, 2022.

 

 

Novusterra Inc.

 

 

 

 

 

By:

/s/ I. Andrew Weeraratne

 

 

Name:

I. Andrew Weeraratne

 

 

Title:

Chief Executive Officer

 

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

 /s/ Mark C. Jensen

 

Chairman of the Board of Directors

 

April 25, 2022 

Mark C. Jensen

 

 

 

 

 

 

 

 

 

 /s/ I. Andrew Weeraratne

 

Chief Executive Officer (Principal Executive Officer)

 

April 25, 2022 

I. Andrew Weeraratne

 

 

 

 

 

 

 

 

 

 /s/ Ray Baum

 

Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

 

April 25, 2022 

Ray Baum

 

 

 

 

 

 

 

 

 

*

 

Director

 

April 25, 2022

Eugene Nichols

 

 

 

 

 

 

 

 

 

*

 

Director

 

April 25, 2022

Goran Antic

 

 

 

 

 

 

 

 

 

*

 

Director

 

April 25, 2022

Byron E Price

 

 

 

 

 

* Pursuant to power of attorney

 

By:

/s/ I. Andrew Weeraratne

 

 

I. Andrew Weeraratne

 

 

Attorney-in-Fact

 

    

 

2

 

EX-5.1 2 nvstrr_ex51.htm OPINION OF COUNSEL nvstrr_ex51.htm

EXHIBIT 5.1

 

Law Office of Clifford J. Hunt, P.A.

8200 Seminole Boulevard

Seminole, Florida 33772

(727) 471-0444 Telephone

(727) 471-0447 Facsimile

www.huntlawgrp.com

 

April 22, 2022

 

I. Andrew Weeraratne, CEO

Novusterra, Inc.

7135 Collins Ave., No. 624

Miami Beach, FL 33760

 

Re:

Registration Statement on Form S-1 for Novusterra, Inc.

 

(Registration No. 333-259924)

 

Dear Mr. Weeraratne:

 

We have acted as counsel to Novusterra, Inc., a Florida corporation (the “Company”), in connection with the preparation and filing of a Registration Statement on Form S-1, File No. 333-259924 (as amended, the “Registration Statement”), filed with the U.S. Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Act”). The Registration Statement relates to the proposed issuance and sale of (i) up to 4,312,500 units of the Company, including the underwriters’ over-allotment option (collectively the “Units”), with each Unit consisting of one share of common stock of the Company, no par value per share (the “Common Stock”); and two accompanying, redeemable warrants of the Company, with each whole warrant entitling the holder thereof to purchase one share of Common Stock (the “Unit Warrants”), (ii) 187,500 warrants entitling the holder thereof to purchase one share of Common Stock (the “Representative Warrants” and, together with the Unit Warrants, the “Warrants”) to be issued to the Representative pursuant to the Underwriting Agreement (defined below), (iii) 187,500 shares of Common Stock underlying the Representative Warrants (the “Representative Shares”) and (iv) 8,625,000 shares of Common Stock underlying the Unit Warrants (“Warrant Shares”). Such Common Stock, Warrants, Representative Shares, Units and Warrant Shares are referred to collectively in this opinion as “Securities.”

 

We are acting as counsel for the Company in connection with the sale by the Company of the Securities. We have made such legal examination and inquiries as we have deemed advisable or necessary for the purpose of rendering this opinion and have examined originals or copies of the following documents and corporate records:

 

 

1.

The Registration Statement, including the exhibits thereto;

 

2.

The form of Underwriting Agreement (the “Underwriting Agreement”), included as Exhibit 1.1 to the Registration Statement;

 

3.

Articles of Incorporation of the Company and amendments thereto, included as Exhibit 3.1 and 3.2 to the Registration Statement;

 

4.

Bylaws of the Company, included as Exhibit 3.3 to the Registration Statement;

 

5.

Resolutions of the Board of Directors authorizing the issuance of the Common Stock and Warrants; and

 

6.

Such other documents and records as we have deemed relevant in connection with this opinion.

 

 

1

 

 

In connection with this opinion, we have examined and relied upon such records, documents, certificates and other instruments as in our judgment are necessary or appropriate to form the basis for the opinions hereinafter set forth. In all such examinations, we have assumed the genuineness of signatures on original documents and the conformity to such original documents of all copies submitted to us as certified, conformed or photostatic copies, and as to certificates of public officials, we have assumed the same to have been properly given and to be accurate. We also have relied upon, with the consent of the Company and its Board of Directors: (i) the representations of the Company, its officers and directors as set forth in the aforementioned documents as to factual matters; and (ii) assurances from the officers and directors of the Company regarding factual representations as we have deemed necessary for purposes of expressing the opinions set forth herein. As to matters of fact material to this opinion, we have relied, without independent verification, upon statements and representations of representatives of the Company and public officials.

 

This opinion is limited in all respects to the Business Corporation Act of the State of Florida (including the applicable provisions of the Florida Constitution and the reported judicial decisions interpreting those laws currently in effect) and, as to the Units, the Common Stock, the Warrants and Warrant Shares constituting legally binding obligations of the Company, solely with respect to the laws of the State of New York, and no opinion is expressed with respect to the laws of any other jurisdiction or any effect which such laws may have on the opinions expressed herein. Our opinion is based on these laws as in effect on the date hereof and as of the effective date of the Registration Statement, and we assume no obligation to revise or supplement this opinion after the effective date of the Registration Statement should the law be changed by legislative action, judicial decision or otherwise. Where our opinions expressed herein refer to events to occur at a future date, we have assumed that there will have been no changes in the relevant law or facts between the date hereof and such future date. Our opinions expressed herein are limited to the matters expressly stated herein and no opinion is implied or may be inferred beyond the matters expressly stated. Not in limitation of the foregoing, we are not rendering any opinion as to the compliance with any other federal or state law, rule or regulation relating to securities, or to the sale or issuance thereof.

 

Based upon the foregoing, and subject to the assumptions, qualifications and limitations set forth herein, we are of the opinion that:

 

1. Units. When the Registration Statement becomes effective under the Securities Act of 1933, as amended (the “Act”), and when the offering is completed as contemplated by the Registration Statement, such Units will be legally binding obligations of the Company, enforceable in accordance with their terms except: (a) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally and by general equitable principles (regardless of whether enforceability is considered in a proceeding in equity or at law); (b) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws; (c) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought; (d) we express no opinion as to whether a state court outside of the State of New York or a federal court of the United States would give effect to the choice of New York law provided for in the Warrant Agreement; and (e) with respect to the Common Stock, we express no opinion to the extent that, notwithstanding its current reservation of shares of Common Stock, future issuances of securities, including the Common Stock, of the Company and/or adjustments to outstanding securities, including the Warrants underlying the Units, of the Company may cause the number of shares of Common Stock underlying the Units, including the Common Stock issuable upon exercise of the Warrants underlying the Units, to exceed the number that remain authorized but unissued.

 

 

2

 

 

2. Common Stock. When the Registration Statement becomes effective under the Act and when the offering is completed as contemplated by the Registration Statement, the 4,312,500 shares of Common Stock will be validly issued, fully paid and non-assessable and the Representative Shares, when issued and sold by the Company and delivered by the Company upon valid exercise thereof and against receipt of the exercise price therefor, in accordance with and in the manner described in the Registration Statement and the Representative Warrants, will be validly issued, fully paid and non-assessable.

 

3. Warrants. When the Registration Statement becomes effective under the Act and when the Warrants are issued, delivered and paid for as contemplated by the Registration Statement, such Warrants will be legally binding obligations of the Company enforceable in accordance with their terms except: (a) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally and by general equitable principles (regardless of whether enforceability is considered in a proceeding in equity or at law); (b) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws; (c) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought; (d) we express no opinion as to whether a state court outside of the State of New York or a federal court of the United States would give effect to the choice of New York law provided for in the Warrant Agreement; (e) with respect to the Common Stock, we express no opinion to the extent that, notwithstanding its current reservation of shares of Common Stock, future issuances of securities, including the Common Stock, of the Company and/or adjustments to outstanding securities, including the Warrants, of the Company may cause the Warrants to be exercisable for more shares of Common Stock than the number that remain authorized but unissued and (f) we have assumed the Exercise Price (as defined in the Warrant Agreement) will not be adjusted to an amount below the par value per share of the Common Stock.

 

4. Warrant Shares. The Warrant Shares, when issued and sold by the Company and delivered by the Company upon valid exercise thereof and against receipt of the exercise price therefor, in accordance with and in the manner described in the Registration Statement and the Unit Warrants, will be validly issued, fully paid and non-assessable.

 

We consent to the filing of this opinion as an exhibit to the Registration Statement and to the reference to us under the caption “Legal Matters” in the prospectus forming a part of the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.

 

 

Sincerely,

 

LAW OFFICE OF CLIFFORD J. HUNT, P.A.

 

 

 

 

 

/s/: Clifford J. Hunt, Esquire

 

 

 

3